MiNK Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INKT research report →
About the company
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies.
- CEO
- Jennifer S. Buell
- IPO
- 2021
- Employees
- 23
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $58.14M
- P/E
- -4.12
- P/S
- 0.00
- P/B
- -4.41
- EV/EBITDA
- -3.95
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 76.02%
- ROIC
- -415.48%
- Revenue
- $0 · 0.00%
- Net Income
- $-12,494,260 · -15.85%
- EPS
- $-2.93 · -1.03%
- Op Income
- $-12,487,304
- FCF YoY
- 37.99%
- 52W High
- $76.00
- 52W Low
- $7.01
- 50D MA
- $11.53
- 200D MA
- $12.06
- Beta
- 0.47
- Avg Volume
- 40.57K
Get TickerSpark's AI analysis on INKT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Ryan Barbara | sell | 500 |
| Jun 4, 26 | Ryan Barbara | sell | 1,000 |
| Jun 1, 26 | Holcomb John Bradley | other | 1,091 |
| Mar 2, 26 | Holcomb John Bradley | other | 1,239 |
| Jun 1, 26 | Ryan Barbara | other | 1,434 |
| Mar 2, 26 | Ryan Barbara | other | 1,629 |
| Jun 1, 26 | Corvese Brian | other | 1,444 |
| Mar 2, 26 | Corvese Brian | other | 1,640 |
| Jun 1, 26 | Behner Peter | other | 1,313 |
| Mar 2, 26 | Behner Peter | other | 1,491 |
Our INKT coverage
Recent articles, reports, and earnings notes.
No research on INKT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INKT report →Similar companies
Peers in the same neighborhood.